Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04306224
Title A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors ImmuneOncia Therapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Washington University School of Medicine - Siteman Cancer Center Saint Louis Missouri 63110 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field